Table 5 Characteristics of a blood test for survivors and deceased in 57 outpatient clinics and 54 group home residents at baseline
From: The vital prognosis of elderly adults living in a group home in their mid-eighties
OPC (n = 53) | GH (n = 46) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Survivors (n = 18–40) | n | Deceased (n = 4–13) | n | p value | Survivors (n = 20) | n | Deceased (n = 18–26) | n | p value | |
TP, g/dl | 6.8 (6.6–7.1) | 39 | 6.9 (6.7–7.3) | 13 | 0.289 | 7.0 (6.7–7.6) | 20 | 6.5 (6.2–7.1) | 26 | 0.014 |
Alb, g/dl | 4.1 (3.9–4.3) | 18 | 4.0 (3.2–4.1) | 4 | 0.227 | 4.0 (3.6–4.3) | 20 | 3.6 (3.3–3.9) | 26 | 0.043 |
Hb, g/dl | 13.0 (11.3–13.7) | 40 | 12.3 (10.6–13.6) | 13 | 0.549 | 12.3 (11.5–13.6) | 20 | 11.4 (10.2–12.3) | 26 | 0.034 |
EPA, μg/ml | 82.5 (46.2–112.5) | 38 | 76.6 (59.2–101.9) | 13 | 0.681 | 34.6 (27.3–57.8) | 20 | 35.6 (20.9–56.2) | 18 | 0.828 |
DHA, μg/ml | 139.4 (115.0–170.5) | 38 | 152.8 (117.0–170.7) | 13 | 0.812 | 126.7 (109.7–146.0) | 20 | 112.2 (81.0–164.3) | 18 | 0.478 |
AA, μg/ml | 151.5 (130.9–194.2) | 38 | 163.5 (126.5–175.5) | 13 | 0.795 | 193.1 (141.0–240.6) | 20 | 183.3 (164.6–204.6) | 18 | 0.762 |
EPA/AA | 0.56(0.31–0.75) | 38 | 0.51 (0.37–0.64) | 13 | 0.673 | 0.20 (0.17–0.28) | 20 | 0.19 (0.14–0.25) | 18 | 0.426 |
LDL-C, mg/dl | 109(95–133) | 40 | 99 (89–140) | 13 | 0.788 | 113 (96–134) | 20 | 108 (97–138) | 21 | 0.824 |
HDL-C, mg/dl | 55(46–65) | 40 | 52 (46–64) | 13 | 0.804 | 52 (45–59) | 20 | 48 (44–54) | 21 | 0.354 |
TG, mg/dl | 102(59–138) | 40 | 90 (69–108) | 13 | 0.379 | 106 (82–125) | 20 | 88(70–115) | 22 | 0.241 |
HbA1c, % | 5.7 (5.6–6.1) | 40 | 5.9 (5.7–6.9) | 13 | 0.289 | 5.3 (4.9–5.6) | 20 | 5.6 (5.2–5.8) | 25 | 0.03 |
BUN, mg/dl | 18.0 (14.5–24.1) | 40 | 16.9 (15.6–22.2) | 13 | 0.926 | 15.1 (12.8–18.7) | 20 | 18.8 (13.9–24.4) | 26 | 0.066 |
CRE, mg/dl | 0.73 (0.62–0.86) | 40 | 0.86 (0.61–1.14) | 13 | 0.420 | 0.69 (0.56–0.84) | 20 | 0.71 (0.54–1.02) | 26 | 0.649 |
AST, U/l | 22 (18–28) | 39 | 22 (19–24) | 13 | 0.758 | 20 (18–23) | 20 | 19 (16–23) | 25 | 0.341 |
ALT, U/l | 16 (12–20) | 39 | 16 (13–17) | 13 | 0.656 | 12 (11–17) | 20 | 13 (10–20) | 25 | 0.872 |
NT-proBNP, pg/ml | 194 (100–471) | 38 | 1064 (579–5809) | 11 | 0.003 | 121 (74–159) | 20 | 272 (160–865) | 26 | 0.001 |